Navigation Links
VetStem Biopharma CEO, Dr. Robert Harman, will Present Data on Stem Cells for Kidney Disease in Poster Session at Feline Veterinary Conference
Date:9/12/2018

Leading regenerative veterinary medicine company, VetStem Biopharma, will be exhibiting at the American Association of Feline Practitioners Conference (AAFP) later this month. The company’s CEO and founder, Dr. Robert Harman, will be presenting data on adipose-derived stem cell therapy for the treatment of chronic kidney disease in felines at a poster session on Saturday, September 29th. The conference is being held in Charlotte, North Carolina September 27-30, 2018.

At the poster session, Dr. Harman will be presenting and answering questions regarding outcome data collected on 40 clinical cases of chronic kidney disease (CKD) in cats that were treated with adipose-derived stem cell therapy. The authors hypothesized that stem cell therapy could improve the clinical course of CKD. Though informal and unblinded, the study concluded that stem cell therapy may provide clinical benefit and be a low-risk treatment option for cats with chronic CKD.

Additional controlled studies are necessary to further evaluate the benefit of adipose-derived stem cell therapy in CKD however these initial results are promising as recent reviews suggest that CKD may be the number one cause of mortality in older felines. While VetStem’s autologous (patient-derived) stem cell service is available to veterinarians in the United States and Canada, the company has plans to work with the FDA to develop an off-the-shelf donor-derived stem cell product for use in feline disease therapy. Currently, the company has three Investigational New Animal Drug applications filed with the FDA.

As the first company to provide adipose-derived stem cell services to veterinarians across the United States and Canada, VetStem Biopharma is considered a leader in the industry of regenerative veterinary medicine. Over 14,000 animals have been treated utilizing the company’s autologous stem cell service. Dr. Harman has been a trailblazer in the field of regenerative medicine for over a decade and presents at both human and animal medical conferences around the world. He most recently spoke in Sacramento at the 2018 North American Veterinary Regenerative Medicine Association Conference. He applies his biotechnology and veterinary experience in the clinical application of stem cell therapy for various types of injuries, illnesses, and other healing-promoting applications. Dr. Harman has also authored 14 peer-reviewed articles and book chapters.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 16 years and 14,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_biopharma_ceo_dr_robert_harman_will_present_data_on_stem_cells_for_kidney_disease_in_poster_session_at_feline_veterinary_conference/prweb15749512.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. CEO of VetStem Biopharma, Dr. Robert Harman, to Present Results of Safety Study for Allogeneic Stem Cell Product at Regenerative Medicine Conference
2. New Patent for Adipose Stem Cells Issued to VetStem Biopharma
3. Dr. Bob Harman, CEO of VetStem Biopharma, Speaks on Stem Cells at Local Rotary Club
4. Dr. Bob Harman of VetStem Biopharma to Speak on the Business of Stem Cells at the Wild West Veterinary Conference
5. VetStem Biopharma CEO and Founder, Dr. Bob Harman, Interviewed in New Book "Stem Cell Therapy: A Rising Tide"
6. New Patent for Adipose Stem Cells Issued to VetStem
7. VetStem Biopharma Regenerative Cell Therapy has been Used on over 13,000 Animals
8. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, will present a clinical abstract on Allogeneic Adipose Stem Cell Bio-Distribution at the Veterinary Orthopedic
9. VetStem Biopharma, Inc., Announces the Opening of its GMP Cell Therapy Manufacturing Facility
10. VetStem Biopharma, Inc. Will Present Data on Two Clinical Conditions and an Industry Overview at the North American Veterinary Regenerative Medicine Association Conference
11. VetStem Biopharma Acquires 24 New Adipose Stem Cell Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... The growth ... challenges for companies to keep up. Traditional Regulatory intelligence (RI) ... adapting technology to get global Regulatory teams right Insights faster and cheaper. With a ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... for preclinical research organizations. It is a low code, GDPR/21 CFR Part ... facilities, innovative technology-driven automated data capture and seamless data and information management. ...
(Date:3/9/2019)... (PRWEB) , ... March 07, 2019 , ... ... is a pioneer in the development and commercialization of high performance, cutting-edge cell ... a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are ...
(Date:2/27/2019)... ... 27, 2019 , ... Lajollacooks4u is pleased to announce that ... and cooking events company will be offering a new cooking package available to ... team-building event involves pairing two popular items together – tacos and tequila – ...
Breaking Biology Technology:
(Date:3/18/2019)... ... March 18, 2019 , ... 3Bar ... microbial solutions announce today they have entered into an agreement for 3Bar to ... for biologic nitrogen fixation for corn. This agreement ensures an easy-to-use solution for ...
(Date:3/13/2019)... ... 2019 , ... Sleep problems constitute a global epidemic that threatens health and ... One billion people worldwide suffer from sleep apnea - a condition that ... of whom go undiagnosed. Today, Beddr , the sleep health technology startup, announced ...
(Date:3/9/2019)... ... March 07, 2019 , ... Murrieta Genomics , ... full day workshop presented by University of California Riverside’s EPIC SBDC focused on ... a.m. to 6 p.m. on Tuesday, March 17, 2019. The location is the Highlander ...
Breaking Biology News(10 mins):